Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Ozonated Oil as a Dietary Supplement in the Clinical Management of Patients With Macular Degeneration

NCT06351033 is registered in ClinicalTrials.gov with Alba Di Pardo as lead sponsor.

NCT NCT06351033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06351033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Ozonated Oil as a Dietary Supplement in the Clinical Management of Patients With Macular Degeneration
Lead sponsor
Alba Di Pardo
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2023
Completion date
December 31, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

maculopathy